4//SEC Filing
Erony Joyce 4
Accession 0001213900-19-012464
CIK 0001609550other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 8:04 PM ET
Size
10.2 KB
Accession
0001213900-19-012464
Insider Transaction Report
Form 4
Erony Joyce
Director10% Owner
Transactions
- Sale
Common Stock
2019-07-09$65.77/sh−38,122$2,507,444→ 400,566 total(indirect: See Footnote) - Sale
Common Stock
2019-07-08$67.60/sh−98,355$6,648,336→ 438,688 total(indirect: See Footnote) - Sale
Common Stock
2019-07-10$66.70/sh−54,715$3,649,430→ 345,851 total(indirect: See Footnote)
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Amzak Health Investors, LLC ("Amzak Health") on June 4, 2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.14 to $69.61. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.465 to $66.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.75 to $67.735. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]These shares are held of record by Amzak Health. The reporting person, a director of the Issuer, and Michael D. Kazma are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein.
Documents
Issuer
Inspire Medical Systems, Inc.
CIK 0001609550
Entity typeother
Related Parties
1- filerCIK 0001459212
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 8:04 PM ET
- Size
- 10.2 KB